Tirzepatide 15mg

Tirzepatide 15mg is a research compound that has gained significant interest in peptide and receptor research. Its dual GIP and GLP-1 receptor activity makes it a widely studied compound in laboratory research. Sequora Peptides offers this 15mg format for research use.

PRICING

$77.00

Quote total for 1 vial(s): $77.00 · Quotations are issued to registered institutions with a verified commercial laboratory address.

Molecular Formula	C225H348N48O68
Molecular Mass	4813.5 g/mol
Monoisotopic Mass	4810.526270 g/mol
Polar Area	2380 Å²
Complexity	13500
XLogP	-42.8
Heavy Atom Count	341
Hydrogen Bond Donor Count	76
Hydrogen Bond Acceptor Count	90
Rotatable Bond Count	189

Independent HPLC + MS verification

Every batch is verified for identity and purity by an independent lab before release.

COA on every vial

Scan your batch code to pull the full certificate — chromatogram included.

Purity guarantee

Material compromised in transit is replaced against the original procurement record.

Buy Tirzepatide 30mg

Tirzepatide is a synthetic 39-amino-acid peptide and a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist developed by Eli Lilly and Company. Unlike selective GLP-1 receptor agonists, tirzepatide activates both incretin pathways within a single molecule, making it an important subject of research in incretin signaling, glucose metabolism, energy regulation, and metabolic biology.

The peptide was designed with structural modifications that extend its circulating half-life, allowing researchers to investigate sustained GIP and GLP-1 receptor activation. Clinical research has produced substantial data on its pharmacological profile. In the SURPASS-2 Phase 3 trial, involving 1,879 participants, tirzepatide produced greater reductions in HbA1c than once-weekly semaglutide at the doses studied.

Tirzepatide has also been extensively investigated in obesity research. The SURMOUNT-1 Phase 3 trial included 2,539 participants and evaluated 5 mg, 10 mg, and 15 mg doses over 72 weeks. The study reported substantial, sustained changes in body weight and improvements across prespecified cardiometabolic measures.

More recent research has extended the SURMOUNT-1 dataset to 176 weeks, examining longer-term outcomes in participants with obesity and prediabetes. The study investigated both sustained weight changes and progression to type 2 diabetes, providing additional data on the long-term effects of tirzepatide exposure.

For laboratory research, tirzepatide provides a well-characterized model for studying dual incretin receptor signaling, peptide pharmacology, metabolic pathways, and GIP/GLP-1 receptor biology.

Research Use Only: This product, and all other prodcuts available at Sequora Peptides, are intended exclusively for laboratory research. It is not intended for human or veterinary use, diagnosis, treatment, or prevention of disease.

Selected Research Papers

Frías JP, et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine.
Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. DOI: 10.1056/NEJMoa2206038.
Tirzepatide for Obesity Treatment and Diabetes Prevention (2024). New England Journal of Medicine. The extended SURMOUNT-1 analysis examined 176-week outcomes in participants with obesity and prediabetes.

Related compounds

DSIP 10mg

COA ✓

DSIP 10mg is a research peptide that has been studied in connection with sleep, stress, and neurobiological processes. Researchers continue to investigate DSIP and its properties in controlled research settings. Offered by Sequora Peptides for research purposes.

$38.00

Tirzepatide 5mg

COA ✓

Tirzepatide 5mg is a research-grade compound studied for its activity at GIP and GLP-1 receptors. Researchers investigate tirzepatide to better understand its properties and potential applications in controlled research.

$44.00

Retatrutide 20mg

COA ✓

Research interest in Retatrutide has grown significantly since clinical studies began evaluating its unique triple-receptor activity. The 20mg Retatrutide format is offered by Sequora Peptides for researchers conducting laboratory and scientific investigations into this investigational peptide and its molecular characteristics.

$145.00

Research use verification

This site supplies chemicals strictly for laboratory research. You must confirm both statements below to enter.

Products are supplied for laboratory research use only and are not for human or veterinary use.